Straumann Holding shares rose Tuesday after the Swiss dental-implant maker lifted its 2025 profitability forecast. The company cited unexpectedly low tariffs and cost savings for the improved outlook, sending its stock higher in Zurich trading.

The firm now expects core EBIT margin expansion of 140 to 170 basis points this year, up sharply from the previous guidance of 30 to 60 basis points. In 2025, Straumann reported a core EBIT margin of 25.2%. Efficiency measures across supply chain and manufacturing are progressing faster than planned, driving stronger-than-expected results across all business segments.

Straumann also noted a more favorable pricing environment in China, adding to the upside. Lower-than-expected tariffs have reduced costs in key markets, while manufacturing productivity improvements are delivering savings ahead of schedule. These factors combined to create a more optimistic profit trajectory than initially projected.

The margin expansion guidance upgrade signals management's confidence in navigating trade headwinds while capitalizing on operational improvements. Investors responded positively to evidence that cost-reduction initiatives are bearing fruit faster than anticipated, particularly given the challenging macroeconomic environment for European exporters.